Log In
Print
BCIQ
Print
Print this Print this
 

pTVG-HP (MVI-816)

  Manage Alerts
Collapse Summary General Information
Company Madison Vaccines Inc.
DescriptionPlasmid DNA vaccine encoding human prostatic acid phosphatase
Molecular Target Prostatic acid phosphatase (PAP) (ACPP)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat hormone naive, biochemically recurrent prostate cancer; Treat metastatic prostate cancer; Treat non-metastatic prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today